Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015
Back to SEC Filings
Material AgreementItem 1.01 · 8-KMEDIUM RiskNeutral

Sarepta Therapeutics, Inc.

The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.

www.sarepta.com
Filed: Sep 23, 2026Cambridge, MassachusettsCIK: 0000873303Healthcare
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Sarepta Therapeutics settled patent infringement litigations with REGENXBIO, UPenn, and Catalent on September 23, 2026, resolving disputes over two U.S. patents with a $39 million charge, reducing legal uncertainty and allowing the company to move forward operationally.

Key Takeaways

Settlement resolves pending patent infringement litigations and appeals involving U.S. Patent Nos. 11,680,274 and 10,526,617

Sarepta recorded a $39.0 million litigation contingency charge to cover the settlement obligations

2 more takeaways

Filing Overview

Form Type8-K
Filing DateSep 23, 2026
Item1.01
CategoryMaterial Agreement
CIK0000873303
Accession #0001193125-26-399416
Risk LevelMEDIUM
SentimentNeutral
Signalrisk
Topics
lawsuitmaterial agreement

What This Means

The company entered into a significant agreement that could materially affect its business. This often signals new partnerships, licensing deals, or major contracts.
View Full Filing on SEC.govBrowse More Filings

Sarepta Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.